Age and Sex Differences in Adverse Events Associated With Antipsychotics: An Analysis of the FDA Adverse Events Database
Alters- und Geschlechtsunterschiede bei unerwünschten Ereignissen unter Antipsychotika: Analyse der FDA-Datenbank für unerwünschte Arzneimittelereignisse
International Journal of Geriatric Psychiatry · 2025-08 · 40 (8)
DOI: 10.1002/gps.70142 ↗Auf einen Blick
In FAERS zeigten sich substanz-, alters- und geschlechtsspezifische Unterschiede bei unerwünschten Ereignissen unter 6 häufig verordneten Antipsychotika. Bei ≥65-Jährigen traten kardiale, extrapyramidal-motorische und sedierende Ereignisse häufiger auf.
Fragestellung
Unterscheiden sich unerwünschte Ereignisse unter 6 häufig verordneten Antipsychotika nach Alter und Geschlecht?
Methode
Analyse von FAERS-Meldungen zu Aripiprazol, Clozapin, Olanzapin, Quetiapin, Risperidon und Haloperidol zwischen Q4 2003 und Q2 2024; 18 AE-Gruppen; adjustierte logistische Regression mit aROR und 95 %-KI.
Ergebnisse
Risperidon: Hyperprolaktinämie aROR 212 (95 %-KI 203–221); Haloperidol: Dystonie aROR 46 (41–51); Aripiprazol: Akathisie aROR 45 (42–49). Ältere hatten häufiger kardiale, motorische und sedierende AE; Jüngere häufiger metabolische AE und Gewichtszunahme.
Schlussfolgerung der Autor:innen
Bei der Behandlung sollten Alter und Geschlecht berücksichtigt werden, um Wirksamkeit und Verträglichkeit der Antipsychotikatherapie zu optimieren.
Kernaussagen
- Risperidon, Haloperidol und Aripiprazol zeigten die höchsten substanzspezifischen aRORs
- ≥65-Jährige hatten häufiger kardiale, extrapyramidal-motorische und sedierende AE
- Frauen meldeten meist höhere Odds; bei Risperidon traten Ausnahmen auf
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Geriatric Psychiatry, online erschienen am 15.08.2025. Verfasst von Tabea Ramin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical Pharmacology, Immanuel Hospital Rüdersdorf, Brandenburg Medical School Theodor Fontane, Rüdersdorf, Germany. Hauptthemen laut MEDLINE: Antipsychotic Agents, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brandenburger Staatsministerium für Wissenschaft, Forschung und Kultur.
Themen: Patientensicherheit
Abstract (Originalsprache)
Objectives
While the risks of antipsychotics in older adults are well recognized, clinical trials often exclude frail older patients, have short follow‐up periods, and provide limited comparative data on specific drugs. This study aimed to explore age‐related differences in the adverse effects of six commonly prescribed antipsychotics using a pharmacovigilance database, with additional analysis of sex‐based variations.
Methods
We analyzed adverse event (AE) reports associated with aripiprazole, clozapine, olanzapine, quetiapine, risperidone, and haloperidol from the FDA Adverse Event Reporting System (FAERS) database between Q4 2003 and Q2 2024. We utilized Standardized MedDRA Queries (SMQs) and self‐defined queries to categorize 18 groups of AEs. Adjusted logistic regression was employed to calculate adjusted reporting odds ratios (aRORs) with 95% confidence intervals (CIs).
Results
Our analysis revealed substance‐specific differences in AE profiles. Risperidone had the highest aROR for hyperprolactinemia (aROR 212, 95% CI 203–221), haloperidol for dystonia (aROR 46, 95% CI 41–51), and aripiprazole for akathisia (aROR 45, 95% CI 42–49). Patients aged 65 and older generally demonstrated a higher likelihood of experiencing cardiac, extrapyramidal motor, and sedative AEs compared to those under 65, with few exceptions across the drugs investigated. In contrast, younger patients showed higher odds for metabolic AEs, including dyslipidemia and hyperglycemia (associated with olanzapine and quetiapine), as well as weight gain (with olanzapine, quetiapine, risperidone, and haloperidol). With few exceptions, women generally showed higher reporting odds of adverse events. Sex‐related differences were especially pronounced for hyperprolactinemia, with 4.7–8.0 times higher reporting odds in women for aripiprazole, olanzapine, quetiapine, and haloperidol—except for risperidone, where a post‐2014 rise in male reports led to higher odds in men. Risperidone was also associated with increased reporting odds of weight gain in men. Additionally, aripiprazole and olanzapine showed 3 to 6 times higher reporting odds for anticholinergic syndrome in men compared to women.
Conclusions
It is essential to consider both age and sex in treatment decisions to optimize the efficacy and tolerability of antipsychotic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Clinical Pharmacology, Immanuel Hospital Rüdersdorf, Brandenburg Medical School Theodor Fontane, Rüdersdorf, Germany.
- Center for Mental Health, Immanuel Hospital Rüdersdorf, Brandenburg Medical School Theodor Fontane, Rüdersdorf, Germany.
- Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane and the Brandenburg University of Technology Cottbus-Senftenberg, Neuruppin, Germany.
ORCID-Profile: Jens-Uwe Peter, Michael Schneider, Volker Dahling, Oliver Zolk
Förderung
- Brandenburger Staatsministerium für Wissenschaft, Forschung und Kultur
Zitieren
APA
Ramin, T., Peter, J. U., Schneider, M., Dahling, V., & Zolk, O. (2025). Age and Sex Differences in Adverse Events Associated With Antipsychotics: An Analysis of the FDA Adverse Events Database. International Journal of Geriatric Psychiatry, 40(8). https://doi.org/10.1002/gps.70142
Vancouver
Ramin T, Peter JU, Schneider M, Dahling V, Zolk O. Age and Sex Differences in Adverse Events Associated With Antipsychotics: An Analysis of the FDA Adverse Events Database. International Journal of Geriatric Psychiatry. 2025;40(8). doi:10.1002/gps.70142
BibTeX
@article{Ramin2025,
author = {Ramin, Tabea and Peter, Jens-Uwe and Schneider, Michael and Dahling, Volker and Zolk, Oliver},
title = {Age and Sex Differences in Adverse Events Associated With Antipsychotics: An Analysis of the FDA Adverse Events Database},
journal = {International Journal of Geriatric Psychiatry},
year = {2025},
volume = {40},
number = {8},
doi = {10.1002/gps.70142}
}
EUVIMED